General Information and Variability Data of DT
DT ID DTD0025
Gene Name SLC22A8
Protein Name Organic anion transporter 3
Synonyms OAT3; SLC22A8; Solute carrier family 22 member 8; hOAT3
Gene ID
9376
UniProt ID
Q8TCC7
TCDB ID
2.A.1.19.34
DT Family Major Facilitator Superfamily (MFS)
Organic Cation Transporter (OCT) Family
Tissue Specificity Expressed in kidney.
Function This transporter may mediates the excretion of endogenous and exogenous organic anions, especially from the brain and kidney. Involved in the transport basolateral of steviol, fexofenadine. Transports benzylpenicillin (PCG), estrone-3-sulfate (E1S), cimetidine (CMD), 2,4-dichloro-phenoxyacetate (2,4-D), p-amino-hippurate (PAH), acyclovir (ACV) and ochratoxin (OTA).
Disease(s) Dyslipidaemias [ICD-11: 5C8Z]
Human immunodeficiency virus infection [ICD-11: 1C62.Z]
Hypercholesterolemia [ICD-11: 5C80.0]
Hyperuricaemia [ICD-11: 5C55.Y]
Influenza virus [ICD-11: 1E30-1E32]
Leukemia [ICD-11: 2A60-2B33]
Type 2 diabetes [ICD-11: 5A11]
Hypercalcemia [ICD-11: 5B91.0]
Methicillin-susceptible staphylococcus aureus [ICD-11: 1B74.0]
Genetic Polymorphisms & Epigenetic Regulations of DT
Species-, Tissue- and Disease-specific Protein Abundances of DT
Exogenous Factor Altering DT Activity
Approved Drug(s) Transported by This DT Acyclovir Drug Info Shingles [ICD-11: 1.00E+91] Approved [1]
Adefovir Drug Info Herpes simplex virus infection [ICD-11: 1F00] Approved [2]
Allopurinol Drug Info Hyperuricaemia [ICD-11: 5C55.Y] Approved [3]
Bumetanide Drug Info Edema associated with congestive heart failure [ICD-11: BD10] Approved [4]
Cefaclor Drug Info Gram-positive & negative bacteria infections [ICD-11: 1A00-1H0Z] Approved [5]
Cefazolin Drug Info Methicillin-susceptible staphylococcus aureus [ICD-11: 1B74.0] Approved [6]
Cefdinir Drug Info Bacterial infections [ICD-11: 1A00-1H0Z] Approved [5]
Cefotiam Drug Info Fungal infections [ICD-11: 1F20-1F2Z] Approved [7]
Ceftizoxime Drug Info Gram-positive & negative bacteria infections [ICD-11: 1A00-1H0Z] Approved [5]
Chlorothiazide Drug Info Edema associated with congestive heart failure [ICD-11: BD10] Approved [8]
Cidofovir Drug Info Cytomegalovirus infections [ICD-11: 1D82] Approved [9]
Cilostazol Drug Info Intermittent claudication [ICD-11: BD40.00] Approved [10]
Cimetidine Drug Info Acid reflux disorder [ICD-11: DA22] Approved [11]
Ciprofloxacin Drug Info Seizure [ICD-11: 8A68] Approved [12]
Dinoprostone Drug Info Medical abortion [ICD-11: JA00.1] Approved [13]
Edaravone Drug Info Amyotrophic lateral sclerosis [ICD-11: 8B60.0] Approved [14]
Estrone sulfate Drug Info Menopausal symptoms [ICD-11: MF32] Approved [15]
Famotidine Drug Info Peptic ulcer [ICD-11: DA61] Approved [16]
Furosemide Drug Info Edema associated with congestive heart failure [ICD-11: BD10] Approved [4]
Ganciclovir Drug Info Cytomegalovirus infections [ICD-11: 1D82] Approved [2]
L-tryptophan Drug Info Depression [ICD-11: 6A8Z] Approved [17]
Mercaptopurine Drug Info Acute lymphoblastic leukemia [ICD-11: 2B33.0] Approved [18]
Methotrexate Drug Info Leukemia [ICD-11: 2A60-2B33] Approved [19]
Olmesartan medoxomil Drug Info High blood pressure [ICD-11: BA00] Approved [20]
Oseltamivir Drug Info Influenza virus [ICD-11: 1E30-1E32] Approved [2]
Pitavastatin calcium Drug Info Dyslipidaemias [ICD-11: 5C8Z] Approved [21]
Prasterone Drug Info Hypercalcemia [ICD-11: 5B91.0] Approved [22]
Pravastatin Drug Info Hypercholesterolemia [ICD-11: 5C80.0] Approved [23]
Ranitidine Drug Info Peptic ulcer [ICD-11: DA61] Approved [16]
Rosuvastatin Drug Info Hypercholesterolemia [ICD-11: 5C80.0] Approved [24]
Saxagliptin Drug Info Type 2 diabetes [ICD-11: 5A11] Approved [25]
Sitagliptin Drug Info Type 2 diabetes [ICD-11: 5A11] Approved [11]
Tenofovir Drug Info Human immunodeficiency virus infection [ICD-11: 1C62.Z] Approved [26]
Tetracycline Drug Info Gram-positive & negative bacteria infections [ICD-11: 1A00-1H0Z] Approved [27]
Trichloromethiazide Drug Info Edema associated with heart failure [ICD-11: BD10.Z] Approved [23]
Valacyclovir Drug Info Shingles [ICD-11: 1.00E+91] Approved [28]
Valsartan Drug Info High blood pressure [ICD-11: BA00] Approved [23]
Zidovudine Drug Info Human immunodeficiency virus infection [ICD-11: 1C62.Z] Approved [28]
Clinical Trial Drug(s) Transported by This DT Benzylpenicillin Drug Info Gram-positive bacteria infections [ICD-11: 1A00-1H0Z] Phase 4 [23]
Dimesna Drug Info Diabetic nephropathy [ICD-11: GB61] Phase 3 [29]
Uric acid Drug Info Acute ischemic stroke [ICD-11: 8B11] Phase 2/3 [30]
Withdrawn, Discontinued or Preclinical Drug(s) Transported by This DT Aminohippuric acid Drug Info Renal function tests [ICD-11: MG02] Withdrawn [22]
Cephaloridine Drug Info Urinary tract infections [ICD-11: GC08] Withdrawn [5]
Prostaglandin f2Alpha Drug Info Solid tumours [ICD-11: 2D4Z] Preclinical [13]
Endogenous Substrate(s) Steviol glucuronide
Endogenous Metabolites (EMs) Handled by This DT 1-methylguanosine EM Info Identified using Oat3-deficient mice [31]
1-methylimidazoleacetate EM Info Identified using Oat3 knockout mice [32]
2-aminophenol sulfate EM Info Identified using Oat3 knockout mice [32]
2-hydroxydecanoate EM Info Identified using Oat3 knockout mice [32]
2-oxindole-3-acetate EM Info Identified using Oat3 knockout mice [32]
2-oxo-9-methylthiononanoic acid EM Info Identified using Oat3-deficient mice [31]
3-hydroxyhexanoate EM Info Identified using Oat3 knockout mice [32]
3-[3-(sulfooxy)phenyl]propanoic acid EM Info Identified using Oat3 knockout mice [32]
4-allylphenol sulfate EM Info Identified using Oat3 knockout mice [32]
4-hydroxyphenylacetate EM Info Identified using Oat3-deficient mice [31]
4-vinylphenol sulfate EM Info Identified using Oat3 knockout mice [32]
7-hydroxyfluphenazine EM Info Identified using Oat3-deficient mice [31]
7-ketodeoxycholate EM Info Identified using Oat3 knockout mice [32]
7-methylguanosine EM Info Identified using Oat3-deficient mice [31]
9-amino-nonanoic acid EM Info Identified using Oat3-deficient mice [31]
9-o-acetylneuraminic acid EM Info Identified using Oat3-deficient mice [31]
Beta-muricholate EM Info Identified using Oat3 knockout mice [32]
Catechol sulfate EM Info Identified using Oat3 knockout mice [32]
Cholic acid EM Info Identified using Oat3 knockout mice [32]
Citrate EM Info Identified using Oat3-deficient mice [31]
Citrulline EM Info Identified using Oat3 knockout mice [32]
Creatinine EM Info Identified using Oat3 knockout mice [33]
Decanedioate EM Info Identified using Oat3 knockout mice [32]
Dehydroascorbic acid EM Info Identified using Oat3-deficient mice [31]
Dehydroepiandrosterone sulfate EM Info Identified using Oat3 knockout mice [34]
Deoxycarnitine EM Info Identified using Oat3 knockout mice [32]
Deoxycholate EM Info Identified using Oat3 knockout mice [32]
Epicatechin 3-O-(3-O-methylgallate) EM Info Identified using Oat3-deficient mice [31]
Equol glucuronide EM Info Identified using Oat3 knockout mice [32]
Equol sulfate EM Info Identified using Oat3 knockout mice [32]
Estrone sulfate EM Info Identified using Oat3 knockout mice [32]
Flavin mononucleotide EM Info Identified using Oat3 knockout mice [35]
Gentisate EM Info Identified using Oat3 knockout mice [32]
Glucuronate EM Info Identified using Oat3 knockout mice [32]
Homostachydrine EM Info Identified using Oat3 knockout mice [32]
Hypotaurine EM Info Identified using Oat3 knockout mice [32]
Imidazole propionate EM Info Identified using Oat3 knockout mice [32]
Indole-3-carboxylic acid EM Info Identified using Oat3 knockout mice [32]
Indoleacetate EM Info Identified using Oat3 knockout mice [32]
Indoleacrylate EM Info Identified using Oat3 knockout mice [32]
Indolelactate EM Info Identified using Oat3 knockout mice [32]
Indolin-2-one EM Info Identified using Oat3 knockout mice [32]
Indoxyl sulfate EM Info Identified using Oat3 knockout mice [32]
Licuroside EM Info Identified using Oat3-deficient mice [31]
Mannitol EM Info Identified using Oat3 knockout mice [32]
Mevalonate EM Info Identified using Oat3 knockout mice [32]
N-acetyltryptophan EM Info Identified using Oat3 knockout mice [32]
N-delta-acetylornithine EM Info Identified using Oat3 knockout mice [32]
O-methylcatechol sulfate EM Info Identified using Oat3 knockout mice [32]
P-cresol glucuronide EM Info Identified using Oat3 knockout mice [32]
P-cresol sulfate EM Info Identified using Oat3 knockout mice [32]
Phenol sulfate EM Info Identified using Oat3 knockout mice [32]
Phenyllactate EM Info Identified using Oat3 knockout mice [32]
Pongamoside A EM Info Identified using Oat3-deficient mice [31]
Pyridoxal EM Info Identified using Oat3 knockout mice [32]
Pyridoxic acid EM Info Identified using Oat3 knockout mice [32]
Salicylate EM Info Identified using Oat3 knockout mice [32]
Sebacate EM Info Identified using Oat3 knockout mice [32]
Serotonin EM Info Identified using Oat3 knockout mice [32]
Sorbitol EM Info Identified using Oat3 knockout mice [32]
Stachydrine EM Info Identified using Oat3 knockout mice [32]
Succinylcarnitine EM Info Identified using Oat3 knockout mice [32]
Tetradecanedioate EM Info Identified using Oat3 knockout mice [32]
Thymidine EM Info Identified using Oat3 knockout mice [35]
Trigonelline EM Info Identified using Oat3 knockout mice [32]
Trimethylamine-N-oxide EM Info Identified using Oat3 knockout mice [32]
Urate EM Info Identified using Oat3 knockout mice [36]
Ursodeoxycholate EM Info Identified using Oat3 knockout mice [32]
Drug-DT Affinity Assessed by Cell Line
Drug(s) with Drug-DT Affinity Data Acyclovir Drug Info Human embryonic kidney cells (HEK293)-OCT2 Km = 772 microM [1]
Adefovir Drug Info BHK-21 cells-OAT3 Km = 1220 microM [37]
Aminohippuric acid Drug Info Oocytes-OAT3 Km = 87.2 microM [22]
Bumetanide Drug Info Proximal tubule (S2) cells-OAT3 Km = 1586 microM [4]
Cimetidine Drug Info Chinese hamster ovary (CHO) cells-OAT3 Km = 174 microM [11]
Cimetidine Drug Info Human embryonic kidney cells (HEK293)-OAT3 Km = 113 microM [38]
Cimetidine Drug Info Human embryonic kidney cells (HEK293)-OAT3 Km = 149 microM [39]
Cimetidine Drug Info Oocytes-OAT3 Km = 57.4 microM [22]
Dimesna Drug Info Human cervical cancer cell line (Hela)-OAT3 Km = 390 microM [29]
Dinoprostone Drug Info Proximal tubule (S2) cells-OAT3 Km = 0.345 microM [13]
Edaravone Drug Info Human embryonic kidney cells (HEK293)-OAT3 Km = 15.1 microM [14]
Estrone sulfate Drug Info Human embryonic kidney cells (HEK293)-OAT3 Km = 6.3 microM [5]
Estrone sulfate Drug Info Human embryonic kidney cells (HEK293)-OAT3 Km = 17 microM [1]
Estrone sulfate Drug Info Monkey kidney fibroblast-like cell (COS)7-OAT3 Km = 2.18 microM [40]
Estrone sulfate Drug Info Oocytes-OAT3 Km = 3.1 microM [22]
Estrone sulfate Drug Info Proximal tubule (S2) cells-OAT3 Km = 2.21 microM [41]
Estrone sulfate Drug Info Proximal tubule (S2) cells-OAT3 Km = 7.5 microM [42]
Famotidine Drug Info Human embryonic kidney cells (HEK293)-OAT3 Km = 124 microM [39]
Methotrexate Drug Info Oocytes-OAT3 Km = 10.9 microM [22]
Methotrexate Drug Info Oocytes-OAT3 Km = 17.2 microM [19]
Methotrexate Drug Info Oocytes-OAT3 Km = 21.1 microM [43]
Methotrexate Drug Info Proximal tubule (S2) cells-OAT3 Km = 21.1 microM [43]
Ochratoxin A Drug Info Proximal tubule (S2) cells-OAT3 Km = 0.75 microM [44]
Olmesartan medoxomil Drug Info Human embryonic kidney cells (HEK293)-OAT3 Km = 0.12 microM [20]
Pitavastatin calcium Drug Info Oocytes-OAT3 Km = 3.3 microM [21]
Pravastatin Drug Info Proximal tubule (S2) cells-OAT3 Km = 27.2 microM [45]
Prostaglandin f2Alpha Drug Info Proximal tubule (S2) cells-OAT3 Km = 1.092 microM [13]
Ranitidine Drug Info Human embryonic kidney cells (HEK293)-OAT3 Km = 234 microM [39]
Rosuvastatin Drug Info Oocytes-OAT3 Km = 7.4 microM [24]
Sitagliptin Drug Info Chinese hamster ovary (CHO) cells-OAT3 Km = 162 microM [11]
Tenofovir Drug Info BHK-21 cells-OAT3 Km = 770 microM [37]
Tetracycline Drug Info Proximal tubule (S2) cells-OAT3 Km = 566.2 microM [27]
Uric acid Drug Info Human embryonic kidney cells (HEK293)-OAT3 Km = 380.3 microM [30]
Valacyclovir Drug Info Proximal tubule (S2) cells-OAT3 Km = 57.9 microM [28]
Zidovudine Drug Info Proximal tubule (S2) cells-OAT3 Km = 145 microM [28]
References
1 Expression of organic anion transporter 2 in the human kidney and its potential role in the tubular secretion of guanine-containing antiviral drugs. Drug Metab Dispos. 2012 Mar;40(3):617-24.
2 FDA Drug Development and Drug Interactions
3 Renal transport of organic compounds mediated by mouse organic anion transporter 3 (mOat3): further substrate specificity of mOat3. Drug Metab Dispos. 2004 May;32(5):479-83.
4 Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Ther. 2004 Mar;308(3):1021-9.
5 Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1. Biochem Pharmacol. 2005 Oct 1;70(7):1104-13.
6 Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases. Pharm Res. 2004 Jan;21(1):61-7.
7 Adaptive responses of renal organic anion transporter 3 (OAT3) during cholestasis. Am J Physiol Renal Physiol. 2008 Jul;295(1):F247-52.
8 Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics. Am J Physiol Renal Physiol. 2008 Apr;294(4):F867-73.
9 Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2). Pharm Res. 2007 Apr;24(4):811-5.
10 Aspirin and probenecid inhibit organic anion transporter 3-mediated renal uptake of cilostazol and probenecid induces metabolism of cilostazol in the rat. Drug Metab Dispos. 2014 Jun;42(6):996-1007.
11 Transport of the dipeptidyl peptidase-4 inhibitor sitagliptin by human organic anion transporter 3, organic anion transporting polypeptide 4C1, and multidrug resistance P-glycoprotein. J Pharmacol Exp Ther. 2007 May;321(2):673-83.
12 Organic anion transporter 3 (oat3/slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin. Mol Pharmacol. 2008 Jul;74(1):122-31.
13 Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins. J Pharmacol Exp Ther. 2002 Apr;301(1):293-8.
14 Human organic anion transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) transport edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and its sulfate conjugate. Drug Metab Dispos. 2007 Aug;35(8):1429-34.
15 Involvement of tyrosine kinase and PI3K in the regulation of OAT3-mediated estrone sulfate transport in isolated rabbit renal proximal tubules. Am J Physiol Renal Physiol. 2005 Nov;289(5):F1057-64.
16 A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters. J Pharmacol Exp Ther. 2005 Oct;315(1):337-45.
17 Murine renal organic anion transporters mOAT1 and mOAT3 facilitate the transport of neuroactive tryptophan metabolites. Am J Physiol Cell Physiol. 2005 Nov;289(5):C1075-84.
18 Organic anion transporter 3 is involved in the brain-to-blood efflux transport of thiopurine nucleobase analogs. J Neurochem. 2004 Aug;90(4):931-41.
19 Methotrexate-loxoprofen interaction: involvement of human organic anion transporters hOAT1 and hOAT3. Drug Metab Pharmacokinet. 2004 Oct;19(5):369-74.
20 Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor. Drug Metab Dispos. 2007 Dec;35(12):2166-76.
21 Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase. J Pharm Pharmacol. 2005 Oct;57(10):1305-11.
22 Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol. 2001 May;59(5):1277-86.
23 Prediction of the overall renal tubular secretion and hepatic clearance of anionic drugs and a renal drug-drug interaction involving organic anion transporter 3 in humans by in vitro uptake experiments. Drug Metab Dispos. 2011 Jun;39(6):1031-8.
24 The contribution of organic anion transporters OAT1 and OAT3 to the renal uptake of rosuvastatin. J Pharmacol Exp Ther. 2007 Sep;322(3):1221-7.
25 Comparative clinical pharmacokinetics of dipeptidyl peptidase-4 inhibitors. Clin Pharmacokinet. 2012 Aug 1;51(8):501-14.
26 Tenofovir alafenamide is not a substrate for renal organic anion transporters (OATs) and does not exhibit OAT-dependent cytotoxicity. Antivir Ther. 2014;19(7):687-92.
27 Human organic anion transporters mediate the transport of tetracycline. Jpn J Pharmacol. 2002 Jan;88(1):69-76.
28 Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther. 2002 Mar;300(3):918-24.
29 In vitro and in vivo assessment of renal drug transporters in the disposition of mesna and dimesna. J Clin Pharmacol. 2012 Apr;52(4):530-42.
30 Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers. Pharm Res. 2008 Mar;25(3):639-46.
31 Multispecific drug transporter Slc22a8 (Oat3) regulates multiple metabolic and signaling pathways. Drug Metab Dispos. 2013 Oct;41(10):1825-34.
32 The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis. J Biol Chem. 2017 Sep 22;292(38):15789-15803.
33 A role for the organic anion transporter OAT3 in renal creatinine secretion in mice. Am J Physiol Renal Physiol. 2012 May 15;302(10):F1293-9.
34 Organic anion transporter 3 mediates the efflux transport of an amphipathic organic anion, dehydroepiandrosterone sulfate, across the blood-brain barrier in mice. Drug Metab Dispos. 2011 May;39(5):814-9.
35 Organic anion transporter 3 contributes to the regulation of blood pressure. J Am Soc Nephrol. 2008 Sep;19(9):1732-40.
36 Multiple organic anion transporters contribute to net renal excretion of uric acid. Physiol Genomics. 2008 Apr 22;33(2):180-92.
37 Novel nucleotide human immunodeficiency virus reverse transcriptase inhibitor GS-9148 with a low nephrotoxic potential: characterization of renal transport and accumulation. Antimicrob Agents Chemother. 2009 Jan;53(1):150-6.
38 Inhibition of oat3-mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and probenecid. Drug Metab Dispos. 2006 May;34(5):743-7.
39 Is the monkey an appropriate animal model to examine drug-drug interactions involving renal clearance? Effect of probenecid on the renal elimination of H2 receptor antagonists. J Pharmacol Exp Ther. 2006 Mar;316(3):1187-94.
40 Novobiocin is a potent inhibitor for human organic anion transporters. Drug Metab Dispos. 2009 Jun;37(6):1203-10.
41 Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters. Eur J Pharmacol. 2001 May 11;419(2-3):113-20.
42 Hydrogen peroxide downregulates human organic anion transporters in the basolateral membrane of the proximal tubule. Life Sci. 2000 Dec 29;68(6):679-87.
43 Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J Pharmacol Exp Ther. 2002 Aug;302(2):666-71.
44 Characterization of ochratoxin A transport by human organic anion transporters. Life Sci. 2001 Sep 21;69(18):2123-35.
45 Inhibition of human organic anion transporter 3 mediated pravastatin transport by gemfibrozil and the metabolites in humans. Xenobiotica. 2007 Apr;37(4):416-26.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.